Un-Audited Financial Results and Press Release for the Quarter ended June 30, 2026
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 04 Aug 2026, 06:55 PM IST · BSE ID: e61d32b9-b377-48f3-bb16-dcebe5f30c54
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its first-quarter financial results for the 2027 fiscal year.
🤖 AI Summary
- Welspun Enterprises Ltd's Board of Directors approved Unaudited Consolidated and Standalone Financial Results for Q1 FY27 on August 4, 2026.
- A Limited Review Report for the quarter ended June 30, 2026, was conducted by Suresh Surana & Associates LLP.
- The Statement of Unaudited Consolidated Financial Results includes 4 subsidiaries, 6 joint operations, and 2 associates reviewed by other auditors.
- The Statement also includes 5 subsidiaries, 12 joint operations, and 1 associate with management-certified financial information not reviewed by auditors.
- Trading window for dealing in company securities by insiders will re-open from Friday, August 7, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this regulatory filing.
👤
Who Is Affected
All shareholders are informed of the board's approval of the quarterly results and the re-opening of the insider trading window.
🔍
Management Signal
Management is fulfilling its regulatory obligations by promptly disclosing Q1 FY27 unaudited financial results and confirming auditor review.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Review the full Unaudited Consolidated Financial Results document for Q1 FY27 figures.
Monitor future regulatory filings for detailed financial performance and operational updates.
Track disclosures related to the Rs. 1,000 Crore fundraising approved in May 2026.
LOW RISK
The filing is a routine disclosure of board actions and regulatory compliance.
💡 Investor Takeaway
Welspun Enterprises Ltd's Board approved unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. The Limited Review Report was completed. Trading window for insiders re-opens August 7, 2026.
📅 Company Track Record
Welspun Enterprises reported consolidated net profit of Rs. 17.51 crores for Q1 FY27 as per a separate filing on August 4, 2026. For FY26, the company's consolidated PAT grew 54% YoY to ₹ 163 Cr, and a dividend of Rs. 3/- per share was recommended, with plans to raise up to Rs. 1,000 Crore.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When did Welspun Enterprises' Board approve the Q1 FY27 unaudited financial results?
The Board of Directors of Welspun Enterprises Limited approved the unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, on August 04, 2026.
Who performed the Limited Review Report for Welspun Enterprises' Q1 FY27 results?
Suresh Surana & Associates LLP, Chartered Accountants, conducted the Independent Auditors Review Report on the Unaudited Consolidated Financial Results for the quarter ended June 30, 2026.
When will the trading window for Welspun Enterprises' securities re-open for insiders?
The trading window for dealing in Welspun Enterprises' securities by insiders will re-open from Friday, August 07, 2026.
What portion of the consolidated financial results were reviewed by other auditors?
Other auditors reviewed interim financial information for 4 subsidiaries, 6 joint operations, and 2 associates. This includes Rs. 286.27 crores total revenue for subsidiaries and Rs. 49.91 crores Group's share of total revenue for joint operations for the quarter ended June 30, 2026.
What financial information was certified by management and not reviewed by auditors for Welspun Enterprises?
Interim financial information for 5 subsidiaries, 12 joint operations, and 1 associate, along with Welspun Enterprises Welfare Trust, was certified by management and not reviewed by auditors for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.